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Abstract
Background: The principle of a capture ELISA is binding of specific capture antibodies (polyclonal or monoclonal)
to the surface of a suitable 96 well plate. These immobilized antibodies are capable of specifically binding a virus
present in a clinical sample. Subsequently, the captured virus is detected using a specific detection antibody. The
drawback of this method is that a capture ELISA can only function for a single virus captured by the primary
antibody. Human Apolipoprotein H (ApoH) or b2-glycoprotein 1 is able to poly-specifically bind viral pathogens.
Replacing specific capture antibodies by ApoH should allow poly-specific capture of different viruses that
subsequently could be revealed using specific detection antibodies. Thus, using a single capture ELISA format
different viruses could be analysed depending on the detection antibody that is applied. In order to demonstrate
that this is a valid approach we show detection of group A rotaviruses from stool samples as a proof of principle
for a new method of capture ELISA that should also be applicable to other viruses.
Results: Stool samples of different circulating common human and potentially zoonotic group A rotavirus strains,
which were pretested in commercial EIAs and genotyped by PCR, were tested in parallel in an ApoH-ELISA set-up
and by quantitative real-time PCR (qPCR). Several control samples were included in the analysis. The ApoH-ELISA
was suitable for the capture of rotavirus-particles and the detection down to 1,000 infectious units (TCID50/ml).
Subsets of diagnostic samples of different G- and P-types were tested positive in the ApoH-ELISA in different
dilutions. Compared to the qPCR results, the analysis showed high sensitivity, specificity and low cross-reactivity for
the ApoH-ELISA, which was confirmed in receiver operating characteristics (ROC) analysis.
Conclusions: In this study the development of a highly sensitive and specific capture ELISA was demonstrated by
combining a poly-specific ApoH capture step with specific detection antibodies using group A rotaviruses as an
example.
Background
Apolipoprotein H (ApoH) is a human plasma protein
able to bind poly-specifically to viruses. Coated onto
magnetic beads or ELISA plates, it enables capture and
concentration of viruses contained in critical diagnostic
samples [1-3]. Common capture assays use specific
poly- or monoclonal antibodies for capture and detec-
tion of viral antigens. These approaches have limitations
since for each virus both a specific capture and a speci-
fic detection antibody are needed. In contrast, ApoH
binds complete viruses and antigens poly-specifically
and therefore offers the chance to capture and detect a
broad range of different viruses within one diagnostic
sample.
Rotaviruses are responsible for the majority of acute
gastroenteritis infections occurring in young children
world wide [4]. The genus Rotavirus belongs to the
family of Reoviridae and, according to the antigenic and
genetic variants of the VP6 region, can be divided into
seven groups named A-G. The majority of human infec-
tions are caused by viruses of group A, which can
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respectively, by VP7 and VP4 antigens. The classification
into sero- and genotype corresponds for G-types while it
is inconsistent in the case of P-types [5,6].
Altogether, 10 G- and 11 P-types have been found in
human group A rotavirus (RV-A) infections, while mostly
types G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8] have
been circulating in Europe in recent years [7]. Addition-
ally, in a few cases, reassortants of human strains, zoonotic
strains and types such as G6, G8, G9, G10 and G12 were
found [8]. The WHO recommends the use of enzyme
immunoassays for the diagnosis of rotavirus infections [9].
This study was initiated to investigate the feasibility
and suitability of a poly-specific virus capture ApoH-
ELISA combined with subsequent sensitive and specific
RV-A detection. The ApoH-ELISA was compared to a
commonly used quantitative real-time PCR (qPCR), to
correctly discriminate positive from negative samples by
the presence of genome equivalents (GE) and to avoid
misclassification by false positive or negative results
using other EIAs. The usefulness of this new method
was assessed in order to show a general feasibility for
the detection of common and rarely circulating RV-A
directly from stool samples after ApoH-mediated bind-
ing to the cavity of a microtitre plate and specific detec-
tion by antibodies. The intention of this study was to
demonstrate the proof of principle of a poly-specific
capture step with subsequent highly specific and sensi-
tive detection of a pathogen and to analyse the potential
of this method for further approaches.
Results
Suitability testing
In the first pre-testing steps it was shown that RV-A
particles were bound to an ApoH-coated ELISA plate as
shown by subsequent RV-A-specific qPCR. A loss of
viral nucleic acid after the binding step to ApoH-ELISA
plates was indicated by higher values (2 CT)i nt h e
qPCR assay compared to directly prepared samples
without ApoH-ELISA incubation.
Detection limit
The detection limit of this ApoH-ELISA assay was esti-
mated by using dilutions of virus stocks obtained by cell
culture with known virus load of infectious particles
(TCID50/ml). Samples containing approximately 1,000
infectious units (TCID50/ml) were reactive in the ApoH-
ELISA (Table 1, nos. 33-39). The best performance was
seen when samples were diluted in NaOAc-buffer (data
not shown).
ApoH-ELISA and qPCR analysis
This study was initiated together with the German Con-
sultant Laboratory for Rotaviruses, using stored left-over
samples from routine diagnostic which were pre-tested
in commonly used EIAs and genotyped by PCR. The
selection criteria for the stool samples were GE and gen-
otype. Therefore, samples were included containing high
and low GE of the most prevalent human strains circu-
lating in Europe in recent years (G1P[8], G2P[4], G3P
[8], G4P[8] and G9P[8]) as well as variants with low pre-
valence, G8P[4] and G12P[6], representing potentially
zoonotic strains (Table 1). These samples were tested in
this study in ApoH-ELISA and qPCR in parallel. Sam-
ples were classified into positive or negative based on
the presence of GE as analysed with a specific and sensi-
tive qPCR assay to avoid potential misclassification (false
negative or positive) by using other EIAs.
The stool samples were tested in three different dilu-
tions (undiluted, 1:10 and 1:100) to investigate the influ-
ence of inhibiting factors potentially present in those
samples that might affect the results of the ELISA.
Three of the 15 samples (Table 1; nos 1, 5, 13) showed
increasing OD values in the ApoH-ELISA for dilutions,
indicating inhibiting factors in the undiluted sample. All
stool samples previously tested positive in PCR and EIA
assays were confirmed positive in the specific qPCR. All
stool samples from the diagnostic pool were reactive in
the new ApoH-ELISA with OD values above 0.5 except
for sample no. 14. This sample showed low values at or
below the threshold in all three dilutions, although the
GE in the qPCR were comparable to other samples (e.g.
no. 4), which resulted in high OD values in the ApoH-
ELISA. Two samples were highly reactive with values
above 3 even in the 1:100 dilutions (nos. 1 and 12).
A broad range of different stool samples with
unknown viral status from human adults and infants
was included as control. Stool samples from different
animals as well as buffers and FCS were tested for
cross-reactivity. Sample no. 19 unexpectedly turned out
to be reactive in the ApoH-ELISA while qPCR showed
very low GE. A similar result was obtained when the
original source sample (Table 1; no. 20) was tested
again. The sample was from a hospitalized Hepatitis A
Virus-positive patient with diarrhoea. Furthermore stool
sample no. 27 taken from a pig which was stalled for an
animal experiment was reactive in the ApoH-ELISA and
positive in the qPCR assays with 135 GE. The GP-typing
of the isolate showed a human G4P[8] origin. Sample
no. 26 was negative in qPCR with relatively high OD
values in the ApoH-ELISA. This sample originated from
a second pig stalled close to the pig from which sample
no. 27 originated, and it can be speculated that in this
case viral antigen was present in the stool after oral
up-take of contaminated faeces, without subsequent
infection of the pig. Further control samples of different
species (mouse, rat, etc.) and buffers (FCS, PBS) did not
show any unspecific signals in the ApoH-ELISA in the
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virus cell culture supernatant showed corresponding
values in both assays.
Receiver operating characteristic (ROC) analysis
The estimation of the area under the ROC-curve (AUC)
is a general test for diagnostic accuracy, and high
values close to 1 indicate a highly accurate test [10].
The results of the qPCR analysis were set as the refer-
ence for the comparison of the ApoH-ELISA results.
The ROC-analysis showed very high and comparable
AUC-values exceeding 0.95, using either the results of
each dilution step separately or all results together as
one matrix (Figure 1, Table 2). The cut-off points of the
method, adjusted to high specificity and high sensitivity,
showed relatively low extinction values below 0.5 OD
Table 1 Results of qPCR and ApoH-ELISA of samples and controls (undiluted, 1:10 or 1:100 dilution)
No. Sample ID Genotype Undiluted sample 1:10 dilution in NaOAc-buffer (50 mM) 1:100 dilution in NaOAc-buffer (50 mM)
direct (qPCR) GE ELISA OD direct (qPCR) GE ELISA 1:10 OD direct (qPCR) GE ELISA OD
1 09g1014 G1P[8] 8.9E+06 2.5224 2.4E+05 3.0000 4.4E+04 3.0000
2 09g429 G1P[8] 7.8E+06 3.0000 1.7E+07 2.2098 2.1E+06 1.2997
3 09g454 G1P[8] 6.5E+06 3.0000 8.6E+05 1.5300 1.0E+05 0.3800
4 09g517 G2P[4] 5.4E+05 3.0000 6.2E+04 3.0000 5.3E+03 1.6400
5 09g991 G2P[4] 8.8E+05 0.6528 1.6E+06 1.8972 7.7E+05 1.1210
6 09g928 G3P[8] 2.4E+08 2.1567 2.9E+07 1.7056 3.6E+06 0.3692
7 09g449 G4P[8] 3.0E+05 3.0000 5.3E+04 1.5100 9.7E+03 0.3900
8 09g451 G4P[8] 1.4E+06 1.0200 8.9E+04 0.7900 1.2E+04 0.2100
9 09g452 G4P[8] 3.5E+08 3.0000 6.7E+07 1.9517 4.3E+06 0.7855
10 09g453 G4P[8] 4.3E+08 3.0000 1.1E+08 1.4608 1.9E+07 0.6903
11 09g1022 G8P(4) 7.2E+07 1.1735 9.0E+06 0.9167 6.7E+05 0.3529
12 09g962 G9P[8] 1.2E+03 3.0000 310 3.0000 20 3.0000
13 09g103 G9P[8] 1.9E+08 1.3311 9.0E+07 1.8673 3.9E+04 2.3071
14 09g410 G9P[8] 3.8E+05 0.2800 5.2E+04 0.1200 4.2E+03 0.0400
15 09g1028 G12P[6] 1.1E+08 2.3188 5.6E+06 1.4600 6.6E+05 0.3582
16 RoA cc1 WA 7.6E+06 2.6300 9.8E+05 2.6900 1.5E+05 2.4100
17 RoA cc2 WA 2.3E+07 2.7957 2.3E+06 2.2964 2.4E+05 0.5170
18 RoA cc3 WA 1.8E+07 2.8673 1.9E+06 2.2590 1.8E+05 0.4448
19 HAV_1 n.s. 4 0.4887 n.a. 0.3276 n.a. 0.1622
20 HAV_2 n.s. 16 0.4200 50 0.2200 12 0.0900
21 Human2 n.a. n.a. 0.2356 n.a. 0.3802 n.a. 0.1210
22 Human3 n.a. n.a. 0.0981 n.a. 0.2047 n.a. 0.0666
23 Wild boar n.a. n.a. 0.0393 n.a. 0.0384 n.a. 0.0367
24 Rat n.a. n.a. 0.0903 n.a. 0.1205 n.a. 0.0189
25 Mouse n.a. n.a. 0.0443 n.a. 0.0304 n.a. 0.0229
26 Pig_1 n.a. n.a. 0.4158 n.a. 0.1632 n.a. 0.0573
27 Pig_2 G4P[8] 135 0.8721 2 0.4551 n.a. 0.1841
28 FCS n.a. n.a. 0.0203 n.a. 0.0189 n.a. 0.0228
29 NaOAc1 n.a. n.a. 0.0358 n.a. 0.0340 n.a. 0.0354
30 NaOAc2 n.a. n.a. 0.0821 n.a. 0.0582 n.a. 0.0658
31 NaOAc3 n.a. n.a. 0.1896 n.a. 0.1233 n.a. 0.0700
32 NaOAc4 n.a. n.a. 0.0217 n.a. 0.0176 n.a. 0.0001
33 CC_dil-2 WA 10,000 IU 1.6464 - - - -
34 CC_dil-3 WA 1,000 IU 0.3173 - - - -
35 CC_dil-4 WA 100 IU 0.0550 - - - -
36 CC_dil-5 WA 10 IU 0.0399 - - - -
37 CC_dil-6 WA 1 IU 0.0297 - - - -
38 CC_dil-7 WA 0.1 IU 0.0286 - - - -
39 CC_dil-8 WA 0.01 IU 0.0315 - - - -
Abbreviations: IU: infectious units TCID50/ml measured in cell culture assay; GE: genome equivalents per reaction; OD: optical density at 450/620 nm; n.a.: no
amplification; n.s.: no sequence result obtained; -: not done; CC_dil: dilution of cell culture virus stock.
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ROC Excel sheet [11] gave high theta0 values close to 1
with a narrow intermediate range (IR) for the undiluted
sample calculation.
Analysis of dependency genome equivalents vs. OD
values
The analysis of dependency between GE and OD extinc-
tion values was run using Spearman’sr a n kt e s t[ 1 2 ] .
One test used only samples that had been tested positive
in qPCR (qPCR = 1, n = 60) for comparison with the
ELISA results. In the prediction test including only
qPCR-positive samples Spearman’s rho was 0.3113 (p =
0.016). Another test included all samples (n = 96) for
the Spearman test, Spearman’s rho was 0.7746 (p <
0.0001). This indicates that a correlation between GE
and resulting OD in the ApoH-ELISA can be assumed,
with a stronger correlation when using the whole data
set also including negative samples.
Discussion
The detection of different RV-A genotypes showed reli-
able results and good performance when using the
newly established ApoH-ELISA. Even samples with very
low GE in qPCR analysis were reactive. This might be
due to a possibly higher amount of viral antigen in
some stool samples compared to viral RNA. Since the
time of sampling in the course of infection is unknown,
no correlation could be drawn between antigen level or
viral genomes and stage of infection. Surprisingly, one
pig sample turned out to be positive for a human RV-A
isolate. The fact that this was one of the pigs that were
held for animal experiments and had daily contact to
humans points to a possible human-to-pig infection
route. Analysing the results of the three dilution steps
per sample subjected to the ApoH-ELISA, all undiluted
samples gave good results. However, increasing extinc-
tion values with increasing dilution steps in three sam-
ples indicated the presence of inhibiting factors that did
not prevent detection of the infection but might result
in underestimating the amount of antigen in the stool
sample if applied undiluted only. A predictable correla-
tion was shown between GE and OD values in the
ELISA. This correlation was stronger when all samples,
qPCR positive and negative, were included instead of
analysing only qPCR positive samples.
Because it is common practice to use stool samples
for the diagnosis of enteral viruses like rotavirus, we did
not use any other material for the testing of the ApoH-
ELISA, except cell culture supernatant during the prior
establishment of the assay. The ApoH-ELISA showed a
good sensitivity and specificity for the detection of
Figure 1 ROC plot of the results for the detection of RV-A
using the new ApoH-ELISA in comparison to the qPCR. The
figure contains the overlay of all results of the ROC (receiver
operating characteristics) analysis for all samples (overall) and for
each dilution step (undiluted, 1:10, 1:100) separately with the
according area under the ROC curve (AUC). The results of the qPCR
analysis of these samples were used as “gold standard” reference.
The ROC plots the true positive rate (sensitivity) against the false
positive rate (1-specificity). The diagonal indicates no discriminatory
power. The plots of the ROC curve for the samples 1:10 and 1:100
dilution were superimposed on each other.
Table 2 Results of the ROC analysis for three separate dilution steps and the combined data set
AUC Cutpoint Sensitivity Specificity Correctly
classified
LR+ LR- theta0 d0 (range) IR upper limit
(range)
lower limit
(range)
VRP
Undiluted 0.9957 ≥ 0.42 95.24% 100.00% 96.88% 0.0476 0.931 0.360
(0.283,
0.653)
0.000 0.416 (0.19,
0.416)
0.424
(0.283,
0.489)
1.003
1:10
diluted
0.9667 ≥ 0.4551 90.00% 100.00% 93.75% 0.1 0.908 0.352 (3, 3) 0.000 0.328 (0.205,
0.328)
2.605 (3,
1.528)
1.764
1:100
diluted
0.9595 ≥ 0.21 89.47% 100.00% 93.75% 0.1053 0.909 0.174 (3,
1.642)
0.000 0.162 (0.067,
0.162)
3.000 (3,
0.383)
1.946
Overall 0.9708 ≥ 0.2122 95.00% 88.89% 92.71% 85.500 0.0562 0.917 0.264
(0.283,
0.416)
0.000 0.236 (0.09,
0.416)
0.571
(0.283,
1.017)
1.112
A non-parametric analysis was performed;
Abbreviations: Overall: all dilution steps were analysed together; AUC: area under the ROC-curve; LR+/LR-: Positive and negative likelihood ration; theta0/d0:
co-ordinates at cut-off point of equivalence with specificity = sensitivity = theta0; IR: intermediate range, VRP: valid range proportion.
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virus, but the low number of stool samples used in this
study is a limitation. As discussed by Philips et al. [13],
ELISA reactivity seems to be a good correlate of disease
in RV-A infection, which is in line with the protocol of
the WHO for surveillance of rotavirus-associated gastro-
enteritis [9]. Because of the initial poly-specific capture
step followed by antibody-dependent specific detection,
this method could then be evaluated in future studies
for the suitability in a differential diagnosis set-up for
the simultaneous detection of other pathogens causing
similar symptoms using just one capture ELISA plate.
The parallel application of pathogen- or genotype-speci-
fic antibodies would allow then at the same time detec-
tion and discrimination on one plate and in one step.
The aim of this study was to demonstrate the proof of
principle and feasibility of the method. Therefore the
rotavirus ApoH-ELISA requires an evaluation and vali-
dation with a quantitatively broader spectrum of clini-
cally relevant stool samples before it can be used in
routine diagnostics of rotaviruses. It will be necessary to
analyse a higher number of samples with clinical data
and it might be valuable to adopt other antibodies
(mono- or polyclonal) for pathogen detection to further
improve performance of the assay. It will also be worth
to carefully evaluate the potential of multiplexing in one
plate for simultaneous detection of different pathogens.
Additionally the ApoH-ELISA will have to be compared
to the “gold standard” EIAs (although the samples were
all previously tested positive in standard EIAs used for
routine diagnostic). Using rotavirus as a model, this
study demonstrates the suitability of a new method for
the specific and sensitive detection of viruses directly
from stool samples by a poly-specific binding of antigen
or complete virus to an ApoH-coated ELISA plate. The
findings of the ApoH-ELISA are in accordance with a
commonly used qPCR test system.
Conclusion
The application of ApoH-ELISA was shown to be prac-
ticable for the diagnostics of RV-A in stool samples,
providing results comparable to a commonly used qPCR
analysis.
Methods
Test samples
A total of 15 human rotavirus-positive stool samples left
over from routine diagnostic and obtained from the Ger-
man Consultant Laboratory for Rotaviruses, were included
(Table 1; nos. 1-15). These stool samples were pre-tested
in commercially used EIAs and by broad-spectrum PCRs.
The samples were additionally genotyped using a multi-
plex PCR for G- and P-type differentiation [14,15]. Alto-
gether 15 relevant isolates of different genotypes and
with different viral loads were chosen. The analysed sam-
ples belonged to the most common human viruses circu-
lating in Europe during recent years and were typed as
G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8]. Addition-
ally, G8P[4] and G12P[6] strains representing potentially
zoonotic isolates were included. Different human stool
samples with unknown viral status for rotavirus from
adults and infants (Table 1; nos. 19-22) were also
included in the analysis.
Furthermore, stool samples from other animal species
(mouse, rat, pig, wild boar) as well as buffer and foetal
calf serum (FCS, Biochrom, Berlin, Germany) served as
controls to test potential cross-reactivity and unspecific
background signals.
ApoH-ELISA
A volume of approximately 100 μl/mg of each stool
sample, virus supernatant or control sample was resus-
pended in 1 mL of NaOAc-buffer (50 mM). Solid parti-
cles were removed by centrifugation at 11,000 rpm for
2 min (Centrifuge 5417R, Eppendorf, Hamburg, Germany).
The supernatant was removed and used undiluted, 1:10
and 1:100 diluted in NaOAc-buffer (50 mM). Altogether
three samples (undiluted, 1:10, 1:100) of each original
sample were used in the final analysis. One aliquot of each
suspension (undiluted, 1:10, 1:100) was used for ApoH-
ELISA detection, another for direct preparation and
measurement of GE in a RV-A-specific qPCR.
For ApoH-ELISA analysis 100 μl of the suspension
were given directly onto the ApoH-ELISA plate. The
plate was then centrifuged for enhanced virus binding at
2,500 rpm for 15 min (Centrifuge Biofuge Stratos, Her-
aeus, Thermo Fisher Scientific, Waltham, MA, USA)
before incubation of the plate for 1 h at 37°C in a CO2
cell incubator (CB150, Binder, Tuttlingen, Germany) in
a humid atmosphere. The supernatant was then
removed from the plate and discarded. The wells were
washed at least three times with 200 μl washing buffer
PBST (PBS with 0.1% Tween20 [Sigma-Aldrich, Ham-
burg, Germany]). A blocking step with 200 μl blocking
buffer (PBST with 2% skimmed milk powder, Sigma-
Aldrich) for 45 min at room temperature was intro-
duced to reduce unspecific signals. The supernatant was
then discarded and another washing step was performed
using PBST. A polyclonal rabbit anti-rotavirus (human)
antibody (DAKOCytomation, Hamburg, Germany)
diluted 1:100 in blocking buffer was used in a volume of
100 μl as first antibody and was incubated on the plate
for 1 h at room temperature. The antibody was then
removed. After washing, 100 μl of the secondary anti-
body were applied for 1 h at room temperature (goat
anti-rabbit POD H&L IgG 1:5000 diluted in blocking
buffer, Dianova, Hamburg, Germany) followed by
an additional washing step. Finally 100 μlo fT M B
Adlhoch et al. Virology Journal 2011, 8:63
http://www.virologyj.com/content/8/1/63
Page 5 of 7(3,3’,5,5’-Tetramethylbenzidine) diluted in substrate buf-
fer (Bio-Rad, Munich, Germany) were added to each
well of the plate. The reaction was stopped with 1 N
H2SO4 after incubation for 20 min at room temperature
in the dark. The plate was analysed in a plate reader
(TECAN Infinite F200, Männedorf, Switzerland) at 450/
620 nm and extinction values were calculated using
Magellan™ Software (TECAN).
Quantitative real-time PCR
One aliquot of the respective dilution for each sample
which was tested in the ApoH-ELISA was analysed in
parallel by qPCR to determine the GE of RV-A.
Av o l u m eo f1 0 0μl of each sample was resuspended
directly in 400 μl AVL lysis buffer (RNeasy viral RNA
kit, Qiagen, Hilden, Germany) and incubated for 10 min
at room temperature followed by RNA extraction
according to the manufacturer’s recommendations. Sub-
sequently, a volume of 20.6 μl of the eluted RNA was
reverse transcribed using the TaqMan
® Reverse Tran-
scription Reagents following the supplier’sp r o t o c o l
(Applied Biosystems, Foster City, USA). RNA was incu-
bated with 2 μl primer mix of random hexamers (R6)/
specific RoA_25/26 primers (RoA_25 gCT TTT AAA
AgT TCT gTT CCg Ag; RoA_26 CTC AAT gTg TAR
TTg Agg TCg, TIB Molbiol, Berlin, Germany) for 30 sec
at 93°C. The sample was snap-cooled on ice to 4°C
before adding the reverse transcription mix containing
4 μl 10xbuffer, 8.8 μlM g C l 2 (25 mM), 3.2 μld N T P
(25 mM), 0.8 μl RNase inhibitor and 0.6 μl reverse tran-
scriptase. The reaction was run in a thermocycler (Mas-
tercycler epgradient, Eppendorf) for 60 min at 42°C
followed by 15 min at 72°C before cooling to 4°C and
storage at -20°C.
T h eG Eo fr o t a v i r u sw e r ed e t e r m i n e db yaq P C R
assay, using 5’ nuclease probes (TaqMan
® probes) with
primer combination RoA_25/26 and probe TM3
(RoA_TM3 probe YAK-CTT ITC CAT CTT TCC gCA
CgC gCT–DB, TIB Molbiol), which was designed to
detect all human and animal RV-A by binding within a
conserved region of the NSP4 gene.
The Platinum
® Taq DNA polymerase kit, MgCl2 and
dNTPs by Invitrogen (Carlsbad, CA, USA) together with
water (Molecular Biology Grade Eppendorf) were
applied in this assay. qPCR reactions were performed in
af i n a lv o l u m eo f2 5μlw i t h2 . 5μl sample, 10xbuffer,
4m Mo fM g C l 2,d N T P0 . 2m Me a c h ,0 . 3μM of each
primer, 0.1 μMo fp r o b e ,R O X0 . 1μM and Platinum
®
Taq 0.5 IU. General reaction conditions for the real-
time assay were 95°C for 15 min and 45 cycles with 95°
C for 15 sec and 60°C for 35 sec. Reactions were run in
an ABI GeneAmp
® 7500 Detection System (Applied
Biosystems). A plasmid pRoA containing the corre-
sponding region of 75 nt from the isolate RV-A WA
(ATCC VR-2018
®) was established. Plasmid DNA was
purified, concentration was determined and copy num-
bers were calculated. The plasmid was 10-fold serially
diluted in water containing l-DNA (1 ng/μl) from 10
6
to 10 copies and used as positive control as well as for
quantification of viral genomes. For qPCR each sample
was analysed in duplicate. Genome equivalents were
determined using a standard curve; the mean and stan-
dard deviation were calculated. The detection limit was
calculated to be 10 cDNA copies per reaction.
As internal sample control a c-myc qPCR assay with
primer combination c-myc_F/R/TM (c-myc F: gCC AgA
ggA ggA ACg AgC T; c-myc R: ggg CCT TTT CAT
TgT TTT CCA; c-myc TM FAM-TgC CCT gCg TgA
CCA gAT CC-BBQ; TIB Molbiol) and a quantified plas-
mid containing the target sequence of 83 nt were
applied for all stool samples. The qPCR reaction condi-
tions corresponded to the RV-A assay.
ApoH-ELISA - suitability testing
In advance, tests to analyse the general binding of rota-
virus particles to ApoH-coated ELISA plates and optimi-
zation steps using different dilution buffers were
performed. For the establishment of the method cell
culture grown virus stock RV-A strain WA with a titre
of 1.3 × 10
7 IU/mL TCID50 [16,17] was used. The virus
suspension was 10-fold serially diluted from 10
-1 to 10
-8
in NaOAc-buffer (50 mM). One aliquot of each dilution
step was used for the ApoH-ELISA assay, and another
aliquot was analysed directly by qPCR for determination
of GE in the sample. First, aliquots of the different sam-
ple dilutions were incubated on the ApoH-ELISA plate
for 1 h at 37°C. Supernatant was removed, the plate was
washed twice with 200 μl PBST and lysis of bound virus
particles was performed directly on the plate using AVL
lysis buffer (RNeasy viral RNA kit, Qiagen). After
10 min of incubation at room temperature samples
underwent RNA extraction and cDNA synthesis and
were stored for further analysis as described before.
A corresponding aliquot was used directly for RNA
extraction, cDNA synthesis and qPCR analysis.
Subsequently, analysis was performed using diluted cell
culture supernatant and ApoH-ELISA to estimate the
detection limit of the ELISA assay by using defined sam-
ples with known virus titre. Therefore the threshold of
the OD values of the ApoH-ELISA can be correlated to
the detection limit of infectious units (TCID50/ml)i nt h e
sample. Cell cultured virus was diluted 10-fold from 10
-1
to 10
-8 either in PBS, NaOAc- (50 mM) or Tris-buffer.
Receiver operating characteristic analysis
Receiver operating characteristic (ROC) analysis was
used to determine a cut-off value (OD) for the newly
established ApoH-ELISA [10,18]. The commonly applied
Adlhoch et al. Virology Journal 2011, 8:63
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Page 6 of 7qPCR was used as reference test to indicate presence or
a b s e n c eo fv i r u si nt h er e s p e c t i v es a m p l ea n dt or u l eo u t
misclassification of samples due to false-negative or
-positive results by other EIA test. With the Youden
Index (sensitivity+specificity-1 [19]) the optimal cut-off
for each dilution step separately and for all samples as a
whole was identified. The ROC analysis was performed
using either the whole data set or the results of each dilu-
tion step separately. The area under the curve (AUC) was
estimated for each of the three dilution steps separately
and for the whole data set. The result of each analysis
was compared to determine a difference in performance
by using dilution steps. Positive and negative likelihood
ratios (LR+ and LR-) were measured and the analysis was
performed using STATA11 (StataCorp LP, College Sta-
tion, TX, USA) and TG-ROC Excel-sheet [11].
Statistical analysis
Spearman test [12] was run using STATA11 (StataCorp
LP) to analyze the correlation between GE in qPCR and
corresponding OD values in ApoH-ELISA.
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